效果比Wegovy还好!礼来减肥药Zepbound在72周内平均减重20%,盘前跳涨2.5%

华尔街见闻
04 Dec 2024

礼来公司近期公布的一项研究结果显示,其减肥药Zepbound在与诺和诺德的Wegovy的首次临床试验中比较重表现更加优异。 在礼来资助的一项临床试验中,使用Zepbound的参与者在72周内平均减轻了20%的体重,而使用诺和诺德的Wegovy的参与者减轻了14%。试验结果证实了早期研究的结论,即Zepbound的减肥效果显著优于竞争对手。 两家公司的竞争一直很激烈,瑞穗分析师Jared Holz曾...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10